Axios @axios
Pfizer has agreed to a licensing deal with the UN's Medicines Patent Pool for its COVID-19 pill that allows generic drug companies to cheaply produce the drug for more than 100 low- and middle-income countries. https://t.co/OSJhRL3vNc — PolitiTweet.org